Since the beginning of the pandemic, scientists worldwide have been working intensely to precisely characterize the novel SARS-CoV2 virus. Only by understanding in detail how the virus is constructed and how it replicates can targets for effective antiviral medications and vaccines be identified. Various Max Planck Institutes are investigating the structure of SARS-CoV2 down to the atomic level, thereby providing valuable insights into the disease. Promising projects from basic research can then be transferred to developing new medications with the help of the Lead Discovery Center.